118 related articles for article (PubMed ID: 17108227)
21. Acute Chlamydia pneumoniae infection in the pathogenesis of autoimmune diseases.
Fujita M; Hatachi S; Yagita M
Lupus; 2009 Feb; 18(2):164-8. PubMed ID: 19151119
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
23. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset.
Romero-Díaz J; García-Sosa I; Sánchez-Guerrero J
J Rheumatol; 2009 Jan; 36(1):68-75. PubMed ID: 19012362
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies.
van Bavel CC; Dieker J; Muller S; Briand JP; Monestier M; Berden JH; van der Vlag J
Mol Immunol; 2009 Dec; 47(2-3):511-6. PubMed ID: 19747733
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
Sjöwall C; Wetterö J
Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
[TBL] [Abstract][Full Text] [Related]
26. Characterization of apoptotic pathway associated with caspase-independent excision of DNA loop domains.
Solovyan VT
Exp Cell Res; 2007 Apr; 313(7):1347-60. PubMed ID: 17362930
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
28. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
[TBL] [Abstract][Full Text] [Related]
30. SLE serum induces classical caspase-dependent apoptosis independent of death receptors.
Bengtsson AA; Gullstrand B; Truedsson L; Sturfelt G
Clin Immunol; 2008 Jan; 126(1):57-66. PubMed ID: 18036993
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
Tan Y; Yu F; Yang H; Chen M; Fang Q; Zhao MH
Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001
[TBL] [Abstract][Full Text] [Related]
32. C-reactive protein and cognitive deficits in systemic lupus erythematosus.
Shucard JL; Gaines JJ; Ambrus J; Shucard DW
Cogn Behav Neurol; 2007 Mar; 20(1):31-7. PubMed ID: 17356342
[TBL] [Abstract][Full Text] [Related]
33. Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis.
Huck S; Deveaud E; Namane A; Zouali M
FASEB J; 1999 Aug; 13(11):1415-22. PubMed ID: 10428765
[TBL] [Abstract][Full Text] [Related]
34. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders.
Ram M; Anaya JM; Barzilai O; Izhaky D; Porat Katz BS; Blank M; Shoenfeld Y
Autoimmun Rev; 2008 Sep; 7(8):621-5. PubMed ID: 18603025
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O
J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955
[TBL] [Abstract][Full Text] [Related]
36. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases.
Orbach H; Zandman-Goddard G; Amital H; Barak V; Szekanecz Z; Szucs G; Danko K; Nagy E; Csepany T; Carvalho JF; Doria A; Shoenfeld Y
Ann N Y Acad Sci; 2007 Aug; 1109():385-400. PubMed ID: 17785327
[TBL] [Abstract][Full Text] [Related]
37. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
38. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients.
Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M
Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851
[TBL] [Abstract][Full Text] [Related]
39. Angiogenic activity in sera of patients with systemic lupus erythematosus.
Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M
Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266
[TBL] [Abstract][Full Text] [Related]
40. [Mechanisms of production and pathogenesis of autoantibodies].
Mimori T
Rinsho Shinkeigaku; 2007 Nov; 47(11):855-7. PubMed ID: 18210817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
